Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2011
Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation
Ryan D Michalek, Valerie A Gerriets, Amanda G Nichols, et al.
Science (New York, N.Y.)
|
November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D Leone, Liang Zhao, Judson M Englert, et al.
Nature
|
February 1, 2019
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress
Mark J Ranek, Kristen M Kokkonen-Simon, Anna Chen, et al.
Cell
|
June 5, 2018
Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR
Zandra E Walton, Chirag H Patel, Rebekah C Brooks, et al.
Journal of the American Chemical Society
|
February 19, 2014
An Fc domain protein-small molecule conjugate as an enhanced immunomodulator
Meng-Jung Chiang, Marc A Holbert, Jay H Kalin, et al.
Science Advances
|
November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 21, 2009
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome
Yvette L Kasamon, Leo Luznik, Mary S Leffell, et al.
The Journal of Clinical Investigation
|
April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Min-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Nature
|
September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemness
Fei Mo, Zhiya Yu, Peng Li, et al.
Oncotarget
|
June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
Katherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2011
Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation
Ryan D Michalek, Valerie A Gerriets, Amanda G Nichols, et al.
Science (New York, N.Y.)
|
November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D Leone, Liang Zhao, Judson M Englert, et al.
Nature
|
February 1, 2019
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress
Mark J Ranek, Kristen M Kokkonen-Simon, Anna Chen, et al.
Cell
|
June 5, 2018
Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR
Zandra E Walton, Chirag H Patel, Rebekah C Brooks, et al.
Journal of the American Chemical Society
|
February 19, 2014
An Fc domain protein-small molecule conjugate as an enhanced immunomodulator
Meng-Jung Chiang, Marc A Holbert, Jay H Kalin, et al.
Science Advances
|
November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 21, 2009
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome
Yvette L Kasamon, Leo Luznik, Mary S Leffell, et al.
The Journal of Clinical Investigation
|
April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Min-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Nature
|
September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemness
Fei Mo, Zhiya Yu, Peng Li, et al.
Oncotarget
|
June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
Katherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.
Page
of 14